Search clinical trials for: Cellular Immune
Total 60145 results
-
Fondazione Italiana Linfomi - ETSAbbVieActive, not recruitingRituximab, Bendamustine and Cytarabine Followed by Venetoclax in High Risk Elderly Patients With MCLLymphoma, Mantle-CellItaly
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingCarcinoma, HepatocellularColombia, Israel, Taiwan, United States, Australia, Brazil, Chile, China, Denmark, France, Germany, Hong Kong, Hungary, Ireland, Italy, Japan, Korea, Republic of, Netherlands, New Zealand, Norway, Portugal, Puerto Rico, Spain, Thailand, Turke... and more
-
Merck Sharp & Dohme LLCCompletedUrothelial Carcinoma Associated 1 RNA, Human
-
Merck Sharp & Dohme LLCActive, not recruitingHepatocellular CarcinomaUnited States, Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, China, Denmark, France, Germany, Hong Kong, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, Malaysia, New Zealand, Norway, Poland, Russian Federation, Spai... and more
-
University of NebraskaNational Cancer Institute (NCI)TerminatedRecurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent... and other conditionsUnited States
-
Hunan Cancer HospitalCompleted
-
Merck Sharp & Dohme LLCCompletedProstatic NeoplasmsUnited States, Argentina, Australia, Austria, Brazil, Canada, Chile, China, Colombia, France, Germany, Ireland, Israel, Italy, Japan, Korea, Republic of, Netherlands, Russian Federation, Spain, Taiwan, United Kingdom
-
Masonic Cancer Center, University of MinnesotaTerminatedCytokine Release Syndrome | Immune and Microbial Reconstitution | Systemic Viral Infection | Acute-graft-versus-host Disease | Chronic Graft-versus-host-disease | Recurrent Malignancy | Allogenic Related Donors | Cell Therapy/Immunotherapy PatientsUnited States
-
Merck Sharp & Dohme LLCEuropean Organisation for Research and Treatment of CancerActive, not recruiting
-
University of WashingtonMerck Sharp & Dohme LLC; Prometheus LaboratoriesTerminatedMetastatic Clear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer | Advanced Clear Cell Renal Cell Carcinoma | Stage IV Renal Cell CancerUnited States
-
Allogene TherapeuticsActive, not recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
Gilead SciencesTerminatedFollicular LymphomaSpain, Italy, France, Poland, Israel, United Kingdom, Czechia, Romania, Australia, Canada
-
Fred Hutchinson Cancer CenterSignalOne Bio, Inc.TerminatedMetastatic Lung Non-Small Cell Carcinoma | Anatomic Stage IV Breast Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Metastatic Malignant Solid Neoplasm | Metastatic Urothelial Carcinoma | Metastatic Triple-Negative Breast CarcinomaUnited States
-
University of Wisconsin, MadisonProstate Cancer Foundation; Madison Vaccines, IncCompletedMetastatic Prostate Carcinoma | Prostate Adenocarcinoma | Metastatic Malignant Neoplasm in the Bone | Metastatic Malignant Neoplasm in the Soft Tissues | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Resistant Prostate CancerUnited States
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompletedRichter Syndrome | Mediastinal Large B-cell Lymphoma
-
Merck Sharp & Dohme LLCCompleted
-
Institute of Hematology & Blood Diseases HospitalCellular Biomedicine Group Ltd.CompletedDiffuse Large B Cell LymphomaChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedBlast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Blasts More Than 5 Percent of Bone Marrow Nucleated Cells | B Acute Lymphoblastic Leukemia With t(9;22)(q34... and other conditionsUnited States
-
Merck Sharp & Dohme LLCCompletedHead and Neck Squamous Cell Cancer
-
Merck Sharp & Dohme LLCCompleted
-
Hunan Cancer HospitalCompletedAnti-PD-1 Antibody Plus Regorafenib in Refractory Microsatellite Stable Metastatic Colorectal CancerMetastatic Colorectal AdenocarcinomaChina
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, HepatocellularKorea, Republic of, China, Hong Kong, Malaysia, Taiwan
-
Peking Union Medical College HospitalEnrolling by invitationLupus Nephritis | Immune Thrombocytopenia | Refractory Systemic Lupus ErythematosusChina
-
Jounce Therapeutics, Inc.Completed
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedLymphomaUnited States, Canada, South Africa
-
Merck Sharp & Dohme LLCActive, not recruitingRenal Cell CarcinomaUnited States, Argentina, Australia, Brazil, Canada, Chile, Colombia, Czechia, Finland, France, Germany, Ireland, Italy, Japan, Korea, Republic of, Netherlands, Poland, Russian Federation, Spain, Taiwan, United Kingdom
-
CRISPR Therapeutics AGViaCyteCompletedGlucose Metabolism Disorders | Immune System Diseases | Autoimmune Diseases | Diabetes Mellitus | Endocrine System Diseases | Diabetes Mellitus, Type 1 | Metabolic DiseaseCanada
-
Sierra Oncology LLC - a GSK companyCompletedAdvanced Solid Tumors or Non-Hodgkin's Lymphoma (NHL)United Kingdom
-
Providence Health & ServicesAvailableKRAS G12V Mutant Advanced Epithelial Cancers
-
Northwestern UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLCActive, not recruitingClassical Hodgkin Lymphoma | Lymphocyte-Depleted Classical Hodgkin Lymphoma | Lymphocyte-Rich Classical Hodgkin Lymphoma | Mixed Cellularity Classical Hodgkin Lymphoma | Nodular Sclerosis Classical Hodgkin LymphomaUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLCActive, not recruitingLymphocyte-Rich Classical Hodgkin Lymphoma | Recurrent Lymphocyte-Depleted Classical Hodgkin Lymphoma | Recurrent Mixed Cellularity Classical Hodgkin Lymphoma | Recurrent Nodular Sclerosis Classical Hodgkin Lymphoma | Refractory Lymphocyte-Depleted Classical Hodgkin Lymphoma | Refractory Mixed... and other conditionsUnited States
-
Tianjin Medical University Cancer Institute and...Cellular Biomedicine Group Ltd.Active, not recruitingNon-Hodgkin's B-cell LymphomaChina
-
RANDBrigham and Women's HospitalCompleted
-
Shanghai Tongji Hospital, Tongji University School...Cellular Biomedicine Group Ltd.Active, not recruitingNon-Hodgkin's B-cell LymphomaChina
-
University College London HospitalsCompletedCardiovascular Diseases | Diffuse Large B Cell Lymphoma | Cardiotoxicity | B-cell Acute Lymphoblastic Leukemia | Primary Mediastinal Large B-cell Lymphoma (PMBCL) | B-cell Lymphoma Refractory | Cardiovascular Complication | B-cell Lymphoma RecurrentUnited Kingdom
-
University of WashingtonTG Therapeutics, Inc.TerminatedHodgkin's LymphomaUnited States
-
Fate TherapeuticsCompletedMelanoma | Lymphoma | Renal Cell Carcinoma | Cervical Cancer | Head and Neck Cancer | Small Cell Lung Cancer | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | NSCLC | Advanced Solid Tumors | HER2-positive Breast Cancer | Pancreas Cancer | Urothelial Carcinoma | Merkel Cell Carcinoma | Microsatellite Instability and other conditionsUnited States
-
Marshfield Clinic Research FoundationCenters for Disease Control and PreventionActive, not recruiting
-
SQZ BiotechnologiesCompletedStudy of SQZ-PBMC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid TumorsAdult Solid TumorUnited States, Canada, Germany
-
University of North Carolina, Chapel HillNational Institute of Allergy and Infectious Diseases (NIAID)Completed
-
Novartis PharmaceuticalsTerminatedSolid TumorsUnited States, Germany, Spain, Belgium, Korea, Republic of, Japan, Italy
-
GenethonActive, not recruitingX-Linked Chronic Granulomatous DiseaseUnited Kingdom
-
Mayo ClinicRegenerative Medicine MinnesotaTerminatedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | Diabetic Kidney Disease | Diabetic Nephropathies | Chronic Kidney Disease | Kidney Failure | Diabetic Nephropathy Type 2 | Kidney InsufficiencyUnited States
-
Gruppo Italiano Malattie EMatologiche dell'AdultoCompletedAcute Lymphoblastic Leukemia | Complete Hematologic Remission (CHR) | Persistent/Recurrent Minimal Residual Disease (MRD)Italy
-
Hospices Civils de LyonCompletedAutoimmune Encephalitis | Paraneoplastic Neurological SyndromeFrance
-
Mustang BioEnrolling by invitationDiffuse Large B Cell Lymphoma | Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) | Hairy Cell Leukemia | Mantle Cell Lymphoma Recurrent | Mantle Cell Lymphoma Refractory | Chronic Lymphocytic Leukemia in Relapse | Small Lymphocytic Lymphoma, Relapsed | Waldenstrom's Macroglobulinemia Recurrent | Follicular B-cell Non-Hodgkin's Lymphoma and other conditionsUnited States
-
AbbVieCompletedHIV Infection | HIV-1 | Human Immunodeficiency Virus (HIV)United States, Australia, Canada, Puerto Rico
-
Talaris Therapeutics Inc.TerminatedTransplanted Organ RejectionUnited States
-
Masonic Cancer Center, University of MinnesotaActive, not recruitingFollicular Lymphoma | Acute Myeloid Leukemia | Multiple Myeloma | Hodgkin Lymphoma | Lymphoplasmacytic Lymphoma | Acute Leukemia | Myelodysplastic Syndrome | Chronic Myelogenous Leukemia | Prolymphocytic Leukemia | Plasma Cell Leukemia | Bone Marrow Failure Syndromes | Burkitt's Lymphoma | Acute Lymphoblastic Leukemia... and other conditionsUnited States